A group of leading medical researchers from around the world announced the formation of a consortium designed to improve the sharing of influenza data, analyze data findings jointly, and publish the results collaboratively as part of the Global Initiative on Sharing Avian Influenza Data (GISAID). This initiative was announced today in a letter published online by the website for the journal Nature. Among the letters 70 signatories are six Nobel laureates.
Data collected under the Initiative will be deposited in three publicly available databases participating in the International Sequence Database Collaboration. GISAIDs policies for rapid and complete data release are modeled upon those already established for other initiatives, such as data on DNA sequence variations in the human genome.
The GISAID consortium not only spans national borders, but scientific disciplines as well, with leaders in the fields of Veterinary Medicine, Human Medicine, Bio-Informatics, and Intellectual Property. This cross-disciplinary effort will provide new means to communicate and share information, as each discipline has distinct interests but also shares similar goals.
The Initiative is coming together to work around restrictions which have previously prevented influenza information sharing, with the hope that more shared information will help researchers understand how viruses spread, evolve, and potentially become pandemic.
The GISAID consortium is open to all scientists, provided they agree to share their own data, credit the use of others data, analyze findings jointly, and publish results collaboratively. The three major publicly available databases participating in the International Sequence Database Collaboration are the EBML in the United Kingdom, DDBJ Japan and US based GenBank. The consortium would publish the data as soon as possible after analysis and validation, with a maximum time window of six months to be reduced in time.
The Initiative has earned widespread international support around the goal of better understanding the spread and evolution of the influenza virus, its transmissibility and pathogenicity. With this goal in mind, the group determined scientists from different fields of expertise needed full access to comprehensive genetic sequencing, clinical and epidemiological data, and analysis from both human and animal isolates in order to better understand the virus and its potential mutation to a pandemic pathogen. It is already hailed as a model for future initiatives.
Â
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
Broadening the Path: Diverse Educational Routes Into Infection Prevention Careers
July 4th 2025Once dominated by nurses, infection prevention now welcomes professionals from public health, lab science, and respiratory therapy—each bringing unique expertise that strengthens patient safety and IPC programs.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.